ֱ

Risk equalization

  • Michel Oskam, Richard van Kleef & René van Vliet (2024), Supplementing risk adjustment with high-risk pooling using historical data for identifying the high-risks, Journal of Risk and Insurance. doi:
  • Van Kleef, R.C., Reuser, M., Stam, P.J. & Van de Ven, W.P.M.M. (2024). A framework for ex-ante evaluation of the potential effects of risk equalization and risk sharing in health insurance markets with regulated competition. Health Economics Review. doi: 
  • Wynand P.M.M. van de Ven & Richard C. van Kleef (2024). A critical review of the use of R2 in risk equalization research. The European Journal of Health Economics. doi:
  • Andreea Panturu, Richard van Kleef, Frank Eijkenaar & Daniëlle Cattel (2024). A Framework for the Design of Risk-Adjustment Models in Health care Provider Payment Systems. Medical Care Research and Review. doi:
  • A.A. Withagen-Koster, R.C. van Kleef & F. Eijkenaar (2024). High-risk pooling for mitigating risk selection incentives in health insurance markets with sophisticated risk equalization: An application based on health survey information. BMC Health Services Research. doi:
  • Van Kleef, R., van Vliet, R. & Oskam, M. (2023). Risk Adjustment in Health Insurance Markets Do Not Overlook the “Real” Healthy. Medical Care, special issue on “STATISTICAL METHODS FOR RISK ADJUSTMENT IN HEALTH CARE”. doi:
  • Richard C. van Kleef, Mieke Reuser, Thomas G. McGuire, John Armstrong, Konstantin Beck,  Shuli Brammli-Greenberg, Randall P. Ellis, Francesco Paolucci, Erik Schokkaert & Juergen Wasem (2024). Scope and Incentives for Risk Selection in Health Insurance Markets with Regulated Competition – A Conceptual Framework and International Comparison, Medical Care Research and Review. doi:
  • Anja Withagen-Koster, Richard van Kleef & Frank Eijkenaar (2023). Predictable profits and losses in a health insurance market with risk equalization: A multiple-contract period perspective. Health Policy, 131: 104763. doi:
  • Michel Oskam, Richard van Kleef & Rudy Douven (2023) Heteroscedasticity of residual spending after risk equalization: a potential source of selection incentives in health insurance markets with premium regulation. The European Journal of Health Economics. doi:
  • Withagen-Koster, A.A., R.C. van Kleef, F. Eijkenaar (2022) Selection incentives in the Dutch Basic Health Insurance: To what extent does end-of-life spending contribute to predictable profits and losses for selective groups? em>MMedical Care Research and Review. doi:
  • Klein, P.P., R.C. van Kleef. J. Henriquez, F. Paolucci (2022) The interplay between risk adjustment and risk rating in voluntary health insurance. em>JJournal of Risk and Insurance. doi:
  • Van de Ven, W., G. Hamstra, R. van Kleef, M. Reuser, P. Stam (2022). The goal of risk equalization in regulated competitive health insurance markets, EEuropean Journal of Health Economics.
  • Van Kleef, R. R. van Vliet (2022) How to deal with persistently low/high spenders in health plan payment systems? em>Health Economics, .
  • Douven, R., L. Kauer, S. Demme, F. Paolucci, W. van de Ven, J. Wasem, X. Zhao (2022). Should administrative costs be included in the risk equalization? An analysis of five countries, EEuropean Journal of Health Economics
  • Antonini, M., R.C. van Kleef, J. Henriquez, F. Paolucci (2021), Can risk rating increase the ability of voluntary deductibles to reduce moral hazard? em>GGeneva Papers on Risk and Insurance, 
  • R. van Kleef, M. Reuser (2021). How the COVID-19 Pandemic Can Distort Risk Adjustment of Health Plan Payment, European Journal of Health Economics. 
  • McGuire, T.G., S. Schillo, and R.C. van Kleef. Very High and Low Residual Spenders in Private Health Insurance Markets: Germany, The Netherlands and the US Marketplaces, em>EEuropean Journal of Health Economics
  • R. van Kleef, F. Eijkenaar, R van Vliet & M. Nielen (2020). Exploiting incomplete information in risk adjustment using constrained regression, American Journal of Health Economics, 
  • T. McGuire, R. van Kleef, S. van Veen, Paying for Mental Health Care in Private Health Insurance in The Netherlands: Some Lessons for the U.S, Psychiatric Services, accepted February 18, 2020/li>
  • Withagen-Koster, A.A., van Kleef, R.C. & Eijkenaar, F. (2020) Incorporating self-reported health measures in risk equalization through constrained regression. EEur J Health Econ.
  • McGuire T., Schillo S., van Kleef R. (2019) Reinsurance, Repayments, and Risk Adjustment in Individual Health Insurance: Germany, The Netherlands and the US Marketplaces,em> American Journal of Health Economics
  • R. van Kleef, T. McGuire, E. Schut, W. van de Ven (2019). Strategies to counteract risk selection in social health insurance markets. Oxford Encyclopedia of Health Economics, Oxford University Press. doi: 10.1093/acrefore/9780190625979.013.62
  • R. van Kleef, F. Eijkenaar, R. van Vliet (2019), Selection incentives for health insurers in the presence of sophisticated risk adjustment, Medical Care Research and Review
  • Eijkenaar, F,, R van Kleef, R van Vliet (2018), Risk equalization in competitive health insurance markets: identifying healthy individuals on the basis of multiple-year low spending, Health Services Research
  • TT.J Layton, T.G. McGuire and R.C. van Kleef. (2018). "Deriving risk adjustment payment weights to maximize efficiency of health insurance markets", Journal of Health Economics,
  • A.A. Withagen-Koster, R.C. van Kleef & F. Eijkenaar (2018). Examining unpriced risk heterogeneity in the Dutch health insurance market. em>The European Journal Of Health Economics. doi: 10.1007/s10198-018-0979-x
  • F. Eijkenaar, R.C.J.A. van Vliet & R.C. van Kleef (2017).   Medical Care, 56 (1), 91-96. doi: 10.1097/MLR.0000000000000828
  • F. Eijkenaar & R.C.J.A. van Vliet (2017).   Health Policy, 121 (11), 1169-1176. doi: 10.1016/j.healthpol.2017.09.007
  • W.P.M.M. van de Ven, R.C.J.A. van Vliet & R.C. van Kleef (2017).   European Journal of Health Economics (HEPAC), 18 (2), 167-180. doi: 10.1007/s10198-016-0764-7
  • F. Eijkenaar & R.C.J.A. van Vliet (2017).   The European Journal Of Health Economics, 19 (2), 203-211. doi:
  • T.J. Layton, R.P. Ellis, T.G. McGuire & R.C. van Kleef (2017).   JJournal of Health Economics, 56, 237-255. doi:
  • R.C. van Kleef, T.G. McGuire, R.C.J.A. van Vliet & W.P.M.M. van de Ven (2017). a href="/">Improving risk equalization with constrained regression.  TThe European Journal Of Health Economics, 18, 1137-1156. doi:
  • S.H.C.M. van Veen, R.C. van Kleef, R.C.J.A. van Vliet & W.P.M.M. van de Ven (2017). a href="/">Exploring the Predictive Power of Interaction Terms in a Sophisticated Risk Equalization Model using Regression Trees.  Health Economics. doi: 10.1002/hec.3523
  • R.C. van Kleef, R.C.J.A. van Vliet & W.P.M.M. van de Ven (2016).   European Journal of Health Economics (HEPAC), 17, 885-895. doi: 10.1007/s10198-015-0729-2
  • K.P.M. van Winssen, R.C. van Kleef & W.P.M.M. van de Ven (2016).  TThe European Journal Of Health Economics, 17 (9), 1059-1072. doi:
  • R.C. van Kleef, R.C.J.A. van Vliet & W.P.M.M. van de Ven (2015). a href="/">Risicoselectie tegengaan met behoud van doelmatigheid.  Economisch-Statistische Berichten, 100 (4720), 628-631.
  • S.H.C.M. van Veen, R.C. van Kleef, W.P.M.M. van de Ven & R.C.J.A. van Vliet (2015).   Medical Care Research and Review, 72 (2), 220-243. doi: 10.1177/1077558715572900
  • W.P.M.M. van de Ven, R.C. van Kleef & R.C.J.A. van Vliet (2015).   Tijdschrift voor Gezondheidswetenschappen, 93 (4), 147-156. doi: 10.1007/s12508-015-0058-y
  • S.H.C.M. van Veen, R.C. van Kleef, W.P.M.M. van de Ven & R.C.J.A. van Vliet (2015).  TThe European Journal Of Health Economics, 16 (2), 201-218. doi:
  • R.C. van Kleef, R.C.J.A. van Vliet & E.M. van Rooijen (2014). a href="/">Diagnoses-based cost groups in the Dutch risk-equalization model: The effects of including outpatient diagnoses.  HHealth Policy, 115(1), 52-59. doi:
  • R.C. van Kleef, R.C.J.A. van Vliet & W.P.M.M. van de Ven (2013). a href="/">Risk equalization in The Netherlands: an empirical evaluation.  EExpert review of pharmacoeconomics & outcomes research, 13 (6), 829-839. doi:
  • R.C. van Kleef, W.P.M.M. van de Ven & R.C.J.A. van Vliet (2013). a href="/">Risk selection in a regulated health insurance market: a review of the concept, possibilities and effects.  EExpert review of pharmacoeconomics & outcomes research, 13 (6), 743-752. doi:

Compare @count study programme

  • @title

    • Duration: @duration
Compare study programmes